➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Medtronic
Baxter
Harvard Business School
AstraZeneca

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dapaconazole

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Dapaconazole?

Dapaconazole is an investigational drug.

There have been 4 clinical trials for Dapaconazole. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2017.

The most common disease conditions in clinical trials are Tinea, Tinea Pedis, and [disabled in preview]. The leading clinical trial sponsors are Biolab Sanus Farmaceutica, Galeno Desenvolvimento de Pesquisas Clínicas, and Gilberto De Nucci.

There is one US patent protecting this investigational drug and twenty-six international patents.

Recent Clinical Trials for Dapaconazole
TitleSponsorPhase
Non-inferiority Trial of Dapaconazole Versus KetoconazoleBiolab Sanus FarmaceuticaPhase 3
Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea PedisBiolab Sanus FarmaceuticaPhase 3
Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea PedisBiolab Sanus FarmaceuticaPhase 2

See all Dapaconazole clinical trials

Clinical Trial Summary for Dapaconazole

Top disease conditions for Dapaconazole
Top clinical trial sponsors for Dapaconazole

See all Dapaconazole clinical trials

US Patents for Dapaconazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dapaconazole   Start Trial Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same Biolab Sanus Farmaceutical Ltda. (Sao Paulo, BR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dapaconazole

Drugname Country Document Number Estimated Expiration Related US Patent
Dapaconazole Argentina 078115 2029-08-28   Start Trial
Dapaconazole Australia 2010286266 2029-08-28   Start Trial
Dapaconazole Brazil PI0904249 2029-08-28   Start Trial
Dapaconazole Canada 2771044 2029-08-28   Start Trial
Dapaconazole Chile 2012000463 2029-08-28   Start Trial
Dapaconazole China 102625800 2029-08-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Medtronic
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.